902 Shares in Axon Enterprise, Inc (NASDAQ:AXON) Bought by S Bank Fund Management Ltd

Key Points

• S Bank Fund Management Ltd has invested approximately $474,000 in Axon Enterprise, Inc., purchasing 902 shares during the first quarter.
• Institutional investors now own 79.08% of Axon's stock, with notable increases in holdings from firms like Capital World Investors and Jennison Associates, reflecting strong institutional interest.
• Recent earnings reports revealed that Axon posted a Q2 net margin of 13.64% and projected an EPS of 5.8 for the current fiscal year, outpacing analysts' expectations.

S Bank Fund Management Ltd acquired a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 902 shares of the biotechnology company's stock, valued at approximately $474,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Brighton Jones LLC purchased a new stake in shares of Axon Enterprise during the 4th quarter valued at about $480,000. Scotia Capital Inc. purchased a new position in shares of Axon Enterprise in the fourth quarter worth approximately $281,000. Kennedy Capital Management LLC purchased a new position in shares of Axon Enterprise in the fourth quarter worth approximately $212,000. Townsquare Capital LLC boosted its holdings in shares of Axon Enterprise by 40.0% in the fourth quarter. Townsquare Capital LLC now owns 913 shares of the biotechnology company's stock worth $542,000 after buying an additional 261 shares during the last quarter. Finally, Sagespring Wealth Partners LLC purchased a new position in shares of Axon Enterprise in the fourth quarter worth approximately $452,000. 79.08% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $831.29, for a total transaction of $8,312,900.00. Following the sale, the chief executive officer owned 3,053,982 shares in the company, valued at $2,538,744,696.78. This trade represents a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Jeffrey C. Kunins sold 7,891 shares of Axon Enterprise stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the sale, the insider owned 144,538 shares in the company, valued at approximately $108,417,953.80. The trade was a 5.18% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 54,995 shares of company stock valued at $41,925,130. Company insiders own 4.40% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on AXON shares. Wolfe Research started coverage on shares of Axon Enterprise in a report on Monday, July 7th. They issued an "outperform" rating on the stock. Craig Hallum raised shares of Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 price objective on the stock in a report on Tuesday, August 5th. UBS Group reissued a "neutral" rating and issued a $840.00 price objective (up previously from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Bank of America raised their price objective on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Finally, Northland Securities set a $800.00 price objective on shares of Axon Enterprise in a report on Tuesday, August 5th. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. According to MarketBeat, Axon Enterprise presently has a consensus rating of "Moderate Buy" and an average target price of $837.69.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock traded up $4.41 on Friday, hitting $754.24. 583,176 shares of the company traded hands, compared to its average volume of 783,867. The stock has a market capitalization of $59.21 billion, a P/E ratio of 186.23, a price-to-earnings-growth ratio of 27.68 and a beta of 1.36. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. Axon Enterprise, Inc has a 52 week low of $346.71 and a 52 week high of $885.91. The business has a 50-day simple moving average of $773.85 and a 200 day simple moving average of $670.30.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.58. The firm had revenue of $668.54 million for the quarter, compared to analysts' expectations of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company's revenue for the quarter was up 32.6% compared to the same quarter last year. During the same quarter last year, the business posted $1.20 earnings per share. Research analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.